Target intelligence / Profile preview

Amyloid precursor protein mRNA 5'-untranslated region iron-responsive element (APP 5'-UTR IRE) (APP 5'-UTR IRE)

Target
APP 5'-UTR IRE
Molecular classification
RNA regulatory element, Iron-responsive element
01

Overview

The Amyloid precursor protein (APP) mRNA 5'-untranslated region (5'-UTR) contains a functional iron-responsive element (IRE) that post-transcriptionally regulates APP synthesis in response to intracellular iron levels (Rogers et al., 2002). This stem-loop structure is a binding site for Iron Regulatory Proteins (IRP1 and IRP2), which act as translational repressors when iron levels are low. In the presence of high iron, IRPs dissociate, allowing for the translation of APP, which has been linked to the pathogenesis of Alzheimer's disease through the subsequent production of neurotoxic amyloid-beta (Aβ) peptides (Cho et al., 2010). Therapeutic strategies targeting this IRE aim to use small molecules to stabilize the IRP-IRE interaction or directly inhibit translation, thereby reducing the total pool of APP available for amyloidogenic processing. This approach is distinct from secretase inhibition as it targets the protein production stage rather than the cleavage stage. Clinical candidates like Posiphen have demonstrated the ability to lower Aβ and tau levels by interacting with this regulatory RNA element (Bandyopadhyay et al., 2013).

Other names
APP IREAmyloid precursor protein iron-responsive elementAPP 5'UTR stem-loopAPP 5'-UTR IRE
02

Mechanism of action

Small molecule binding to the IRE stem-loop or stabilization of the Iron Regulatory Protein (IRP) complex to inhibit the translation of APP mRNA, thereby reducing the production of amyloid precursor protein and its neurotoxic cleavage products (Rogers et al., 2002; Bandyopadhyay et al., 2013).

03

Biological functions

Translation regulationIron homeostasisProtein synthesis control
04

Disease associations

Alzheimer's diseaseNeurodegenerative diseaseCerebral amyloid angiopathy
05

Safety considerations

Potential off-target inhibition of other IRE-containing mRNAs (e.g., ferritin, transferrin receptor)Disruption of systemic iron homeostasisPotential for long-term neurological effects from chronic APP suppression
06

Interacting drugs

Posiphen

3 more in the full profile.

07

Biomarkers

Amyloid-beta 42 (Aβ42) levelsAmyloid-beta 40 (Aβ40) levelsSoluble APP alpha (sAPPα)Soluble APP beta (sAPPβ)

Beyond the preview

Go deeper on Amyloid precursor protein mRNA 5'-untranslated region iron-responsive element (APP 5'-UTR IRE) (APP 5'-UTR IRE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amyloid precursor protein mRNA 5'-untranslated region iron-responsive element (APP 5'-UTR IRE) (APP 5'-UTR IRE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call